Moreover, the levels of expression of other glioma stemness markers like ATP-binding cassette superfamily G member 2 (ABCG2) and CD44 were also increased with PGRN overexpression and decreased with PGRN knockdown, clearly indicating the role of PGRN in regulating the stemness of GBM. Here, GRN is linked to central nervous system cancer.